95M-14683-12904
4 vaccinations
2 coded responses
43 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 559 / MN
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Registered in v-safe
-
2021-01-08
Dose 1 — Pfizer-BioNTech
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-15
- 2021-01-22
-
2021-01-29
Dose 2 — Pfizer-BioNTech
- 2021-01-29
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body achesAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-02-26
-
2021-03-05
Survey response — day 35, dose 2MedDRA: SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Good · Be unable to do your normal daily activitiesFree text: Upper respiratory infection- tested negative for covidMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-12
- 2021-04-30
- 2021-08-04
-
2021-09-27
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-12-27
- 2022-03-28
-
2022-09-15
Dose 4 — Pfizer-BioNTech
- 2022-09-27
- 2022-09-28
- 2022-09-29
- 2022-10-08
- 2022-10-13
- 2022-10-21
-
2022-10-27
Survey response — day 42, dose 4MedDRA: Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: RsvMedDRA releases: 2024-11 · check-in free text available
- 2022-12-15
- 2023-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
| 4 | 2022-09-15 | Pfizer-BioNTech | No |
Free text
Release 5 — day 35, dose 2
Symptoms: Upper respiratory infection- tested negative for covid
Release 12 — day 42, dose 4
Symptoms: Rsv
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release